Funding Opportunity Announcements

Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)- RFA-AI-21-079U19December 23, 2021June 04, 2022Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006R01December 21, 2021January 08, 2023Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection- NOT-HL-22-004R01, R21December 21, 2021September 08, 2025Notice of Special Interest (NOSI)—Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)- NOT-OD-22-026SuppDecember 16, 2021March 17, 2022Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Universal Influenza Vaccine- NOT-AI-22-013R01, R21December 13, 2021January 08, 2025Notice of Special Interest (NOSI)—Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection- NOT-OD-22-038SuppDecember 07, 2021January 25, 2022Medical Scientist Training Program (T32)- PAR-21-189T32December 07, 2021January 26, 2024Limited Competition—Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)- PAR-21-356U42December 03, 2021September 26, 2023Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)- NOT-OD-22-030SuppDecember 02, 2021January 27, 2023Notice of Special Interest (NOSI)—Research on the Health of Women of Understudied, Underrepresented, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-031SuppDecember 02, 2021February 01, 2023Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-032SuppDecember 02, 2021February 01, 2024Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery- NOT-AI-22-014R01December 01, 2021January 08, 2025Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity- NOT-AI-21-082R01, R21November 29, 2021January 08, 2025Notice of Special Interest (NOSI)—Accelerating Progress in Celiac Disease Research- NOT-AI-22-004MultipleNovember 23, 2021January 08, 2025Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)- PAR-22-073SuppNovember 19, 2021February 03, 2024Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)- PAR-21-343U01November 19, 2021April 19, 2024Pre-application—Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)- PAR-21-342X02November 19, 2021December 14, 2023Limited Competition—Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)- PAR-22-056U42November 03, 2021September 26, 2022RePORT International Coordinating Center (RICC) (U01 Clinical Trial Not Allowed)- RFA-AI-21-078U01November 02, 2021March 18, 2022Notice of Special Interest (NOSI)—Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity- NOT-AI-21-072R21October 20, 2021January 08, 2025Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-21-075R01October 18, 2021February 09, 2022Notice of Special Interest (NOSI)—Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes- NOT-AI-21-080R21, R01October 18, 2021January 08, 2025Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed)- RFA-AI-21-070R01October 15, 2021February 19, 2022Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed)- RFA-AI-21-065U19September 27, 2021January 15, 2022Notice of Special Interest (NOSI)—Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)- NOT-AI-21-074SuppSeptember 24, 2021September 24, 2024